Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 6,450.00
-140.00 (-2.12%)
Oct 10, 2025, 3:30 PM KST
Komipharm International Market Cap
Komipharm International has a market cap or net worth of 463.55 billion as of October 10, 2025. Its market cap has increased by 65.56% in one year.
Market Cap
463.55B
Enterprise Value
486.44B
Revenue
54.81B
Ranking
n/a
PE Ratio
110.20
Stock Price
6,450.00
Market Cap Chart
Since March 1, 2002, Komipharm International's market cap has increased from 94.26B to 463.55B, an increase of 391.77%. That is a compound annual growth rate of 6.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 463.55B | 73.34% |
| Dec 30, 2024 | 267.41B | -9.03% |
| Dec 28, 2023 | 293.94B | -34.10% |
| Dec 29, 2022 | 446.06B | -18.67% |
| Dec 30, 2021 | 548.45B | -36.13% |
| Dec 30, 2020 | 858.75B | -11.44% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.17T |
| Celltrion | 38.24T |
| ALTEOGEN | 24.66T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,136.75B |
| Peptron | 6,866.96B |
| PharmaResearch | 5,631.19B |
| LigaChem Biosciences | 5,545.53B |